Home > Healthcare > Pharmaceuticals > Finished Drug Form > Demulcent Eye Drops Market

Demulcent Eye Drops Market Trends

Report ID: GMI5351
Published Date: Sep 2022
Report Format: PDF

Download Free Sample

Demulcent Eye Drops Market Trends

One of the key factors preventing the business from growing is the fact that demulcent eye drops, which are readily available over-the-counter, have a variety of negative effects. These eye drops are preserved using ingredients including purite, EDTA, and BAK to maintain pH level of tear film. Excessive or incorrect usage of such medications may cause adverse reactions such as allergies and ocular toxicity. The looming chances of discontinuation of certain ocular eye drops with preservatives may restrain the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for demulcent eye drop was valued at over USD 1.8 billion in 2021 and is predicted to rise at a CAGR of over 6% through 2030, owing to an increase in the incidence rate of eye ailments worldwide.

The polyols segment was valued over USD 550 million in 2021 and will exhibit a significant growth during the forecast period, owing to its usage for treatment of digital eye strain, retinal diseases, and other eye conditions.

The non-preservative-based formulation segment held a sizable market share in 2021 and is projected to surpass USD 1 billion by 2030, owing to its increasing usage resulting from growing awareness of the eye-health risks caused by preservatives.

Top enterprises such as Johnson and Johnson Services Inc., Alcon Inc., OASIS Medical, Allegan (AbbVie Inc.), Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co. Ltd., Bausch Health Companies Inc., Aurolab, and others form the competitive landscape of the global demulcent eye drops market.